L6J.F AIFORIA TECHNOLOGIES OYJ
- Market cap
- EUR 30.4M
- P/E
- -
- P/B
- 1.84x
- ROE
- -74.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is L6J.F undervalued?
Graham numberThe Graham number of AIFORIA TECHNOLOGIES OYJ cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
AIFORIA TECHNOLOGIES OYJ fundamental analysis
No fundamental analysis for AIFORIA TECHNOLOGIES OYJ yet.
AIFORIA TECHNOLOGIES OYJ stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About AIFORIA TECHNOLOGIES OYJ
Aiforia Technologies Oyj, together with its subsidiary, Aiforia Inc., provides AI-based image analysis software used in clinical, preclinical, and academic laboratories to pathologists and researchers in Finland, rest of Europe, North America, and internationally. It offers tools for AI-supported diagnostics and visualization of patient samples, as well as automated screening and reporting tools for the treatment of various cancers, such as breast, lung, and prostate cancer;…
Full company profileAIFORIA TECHNOLOGIES OYJ financial statements
AIFORIA TECHNOLOGIES OYJ annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 974K | 1.61M | 2.40M | 2.85M | 3.54M |
| Gross Profit | 974K | 1.04M | 1.93M | 2.25M | 2.59M |
| Operating Income | -4.69M | -12.0M | -12.9M | -12.2M | -11.2M |
| EBITDA | - | -9.79M | -9.56M | -7.51M | -6.98M |
| Net Income | -7.58M | -12.2M | -12.9M | -11.9M | -12.7M |
| EPS | -0.29 | -0.47 | -0.50 | -0.41 | -0.40 |
| Balance Sheet | |||||
| Total Assets | 43.9M | 36.5M | 28.2M | 28.4M | 29.2M |
| Total Liabilities | 5.98M | 7.18M | 10.3M | 11.8M | 12.1M |
| Shareholders' Equity | 37.9M | 29.3M | 17.9M | 16.6M | 17.1M |
| Cash & Short-term Investments | 38.1M | 24.7M | 14.0M | 11.5M | 9.53M |
| Cash Flow | |||||
| Operating Cash Flow | -2.45M | -8.85M | -8.16M | -7.80M | -7.59M |
| Capital Expenditure | 3.79M | 6.39M | 5.99M | 5.59M | 6.65M |
| Free Cash Flow | -6.24M | -15.2M | -14.1M | -13.4M | -14.2M |
| Ratios | |||||
| ROE | -20.0% | -41.5% | -72.2% | -72.1% | -74.3% |
| ROA | -17.2% | -33.3% | -45.8% | -42.1% | -43.4% |
| Net Profit Margin | -777.8% | -756.9% | -539.0% | -418.9% | -358.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
AIFORIA TECHNOLOGIES OYJ dividends
AIFORIA TECHNOLOGIES OYJ has not paid dividends in the last 5 fiscal years.
Who owns AIFORIA TECHNOLOGIES OYJ
- Insiders 33.38%
- Institutions 13.07%
- Public & others 53.55%
- Shares outstanding 37.4M
- Free float 19.1M
AIFORIA TECHNOLOGIES OYJ company profile
- Company name
- AIFORIA TECHNOLOGIES OYJ
- Ticker
- L6J.F
- ISIN
- FI4000507934
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 67
- Fiscal year end
- December
- Address
- Pursimiehenkatu 29-31 D 610, Helsinki, Finland, 00150
- Phone
- 358 2073 49130
- Website
- aiforia.com
About AIFORIA TECHNOLOGIES OYJ
Aiforia Technologies Oyj, together with its subsidiary, Aiforia Inc., provides AI-based image analysis software used in clinical, preclinical, and academic laboratories to pathologists and researchers in Finland, rest of Europe, North America, and internationally. It offers tools for AI-supported diagnostics and visualization of patient samples, as well as automated screening and reporting tools for the treatment of various cancers, such as breast, lung, and prostate cancer; CE-IVD marked Aiforia clinical suite viewer for the clinical pathology workflow; and Aiforia Create, an agile solution to develop an AI model for image analysis application. The company's products are used for the treatment of Parkinson's disease, organ transplantation, and liver and inflammatory bowel diseases. The company serves academic institutes and pharmaceutical companies through direct and sales partners. Aiforia Technologies Oyj was incorporated in 2013 and is headquartered in Helsinki, Finland.
AIFORIA TECHNOLOGIES OYJ management
8- Mr. Jukka Tapaninen M.Sc(Econ)Chief Executive Officer · born 1963
- Dr. Johan Lundin M.D., Ph.D.Co- Founder & Director · born 1964
- Mr. Antti Ojala M.Sc.Chief Financial Officer · born 1979
- Ms. Kaisa HelminenChief Operating Officer · born 1975
- Mr. Thomas Rosqvist M.Sc.Chief Technology Officer · born 1983
- Mr. Manuel AhlstenVice President of Marketing
- Mr. Panu KauppilaChief Product Officer
- Mr. Federico SebastianiChief Commercial Officer (CCO)